i am a physician


Worried about your prostate disease? Afraid of major prostate surgery and painful symptoms?


Worried about your prostate disease? Afraid of major prostate surgery and painful symptoms?

Sonablate Corporation is committed and continuously working to make its electronic and information technologies accessible to individuals with disabilities by meeting or exceeding the requirements of Section 508 of the Rehabilitation Act (29 U.S.C. 794d), as amended in 1998.

Section 508 is a federal law that requires organizations to provide individuals with disabilities equal access to electronic information and data comparable to those who do not have disabilities, unless an undue burden would be imposed on the agency.

The Section 508 standards are the technical requirements and criteria that are used to measure conformance within this law. More information on Section 508 and the technical standards can be found at www.section508.gov.

If you require assistance or wish to report an issue related to the accessibility of any content on this website, please email accessibility@trackablemed.com. If applicable, please include the web address or URL and the specific problems you have encountered.

You may also contact a representative from the TrackableMed Accessibility Team by calling (855) 219-9984.

Sonablate® HIFU is approved in more than 50 countries worldwide and was the first focused ultrasound device to be FDA-cleared in the U.S. for the ablation of prostate tissue. This innovative solution for prostate diseases has allowed Sonablate® HIFU to become the industry leader in focal therapy. Sonablate is a minimally invasive device intended for precise planning and monitoring of ultrasound imaging and high intensity focused ultrasound to ablate prostate tissue. Most common side effects include pain and discomfort and urinary tract infection (UTI). Rare side effects include rectal injury, which may require intervention. Consult your physician to see if the Sonablate procedure is right for you.

© 2023 Sonablate Corp. All Rights Reserved.